A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 in patients with mCRPC.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael Paul Kolinsky, Pasquale Rescigno, Diletta Bianchini, Zafeiris Zafeiriou, Niven Mehra, Joaquin Mateo, Ruth Riisnaes, Mateus Crespo, Ines Figueiredo, Penelope Flohr, Nina Tunariu, Udai Banerji, Florence I. Raynaud, Karen E Swales, Holly Tovey, Nuria Porta, Rachel Slade, Lorna Leonard, Emma Hall, Johann S. De Bono
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602056302